PARP inhibitors and the treatment of breast cancer: beyond BRCA1/2?
Author:
Publisher
Springer Science and Business Media LLC
Link
http://link.springer.com/content/pdf/10.1186/bcr2451.pdf
Reference15 articles.
1. Inbar-Rozensal D, Castiel A, Visochek L, Castel D, Dantzer F, Izraeli S, Cohen-Armon M: A selective eradication of human nonhereditary breast cancer cells by phenanthridine-derived polyADP-ribose polymerase inhibitors. Breast Cancer Res. 2009, 11: R78-10.1186/bcr2445.
2. Kim MY, Zhang T, Kraus WL: Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD+ into a nuclear signal. Genes Dev. 2005, 19: 1951-1967. 10.1101/gad.1331805.
3. Kraus WL: Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation. Curr Opin Cell Biol. 2008, 20: 294-302. 10.1016/j.ceb.2008.03.006.
4. Kling J: PARP inhibitors blaze a trail in difficult-to-treat cancers. Nat Biotechnol. 2009, 27: 784-786. 10.1038/nbt0909-784.
5. Drew Y, Calvert H: The potential of PARP inhibitors in genetic breast and ovarian cancers. Ann N Y Acad Sci. 2008, 1138: 136-145. 10.1196/annals.1414.020.
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The expanding universe of PARP1-mediated molecular and therapeutic mechanisms;Molecular Cell;2022-06
2. Suppression of isoprenylcysteine carboxylmethyltransferase compromises DNA damage repair;Life Science Alliance;2021-10-05
3. Estrogen enhances the cytotoxicity of PARP inhibitors on breast cancer cells through stimulating nitric oxide production;The Journal of Steroid Biochemistry and Molecular Biology;2021-05
4. The high expression of NUDT5 indicates poor prognosis of breast cancer by modulating AKT / Cyclin D signaling;PLOS ONE;2021-02-11
5. Synthesis, chemical characterization, PARP inhibition, DNA binding and cellular uptake of novel ruthenium(II)-arene complexes bearing benzamide derivatives in human breast cancer cells;Journal of Inorganic Biochemistry;2020-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3